More Articles

Bill introduced to allow generics to change labelling Policies & Legislation | Posted 27/04/2012

A new bill aims to address a recent Supreme Court decision that threatens to undermine the safety of consumers taking generic drugs.

Novartis versus the Indian patent system Biosimilars/News | Posted 27/04/2012

The Indian patent system is once again under scrutiny as a final decision in the case of Novartis versus the Indian patent system is eagerly awaited by originator biologicals and biosimilars manufa...

Turkish guidelines for biosimilars Guidelines | Posted 27/04/2012

Last update:  27 April 2012 The regulatory body for approval of medicines in Turkey is the General Directorate of Pharmaceuticals and Pharmacy (GDPP). The agency is responsible, under the...

Removal of barriers for the global development of biosimilars Conferences | Posted 23/04/2012

At the 2012 Biosimilars Medicines: 10th EGA International Symposium, held in London, UK, on 19–20 April 2012; Mr Nils Behrndt (Deputy Head of Cabinet DG Sanco, European Commission) announced t...

CMS rules add to US drug shortages Pharma News | Posted 23/04/2012

Results of a survey carried out by the Institute for Safe Medication Practices (ISMP) and published on 22 March 2012 point to the fact that ‘too strict’ rules from the US Centers for Medicare &...

European Commission calls for wider use of generic medicines Conferences | Posted 23/04/2012

At the 10th International Symposium on Biosimilar Medicines, organised by the European Generics medicines Association, held in London, UK, on 19–20 April 2012; the European Commission (EC) hig...

Samsung to launch biosimilars by 2015 at half the current prices Biosimilars/News | Posted 23/04/2012

South Korean electronics giant Samsung told the Financial Times that it plans to launch biosimilars by 2015 at half the prices that patients in Europe and the US currently pay.

US Supreme Court rules against generics delaying tactics Generics/News | Posted 23/04/2012

On 17 April 2012, the US Supreme Court ruled in favour of India-based generics company Sun Pharma in its case against Danish pharmaceutical company, Novo Nordisk, a case that could have provided a...